The role of histone modifications in the development of metabolic dysfunction-associated steatotic liver disease

dc.contributor.author	Aleksandrova, Tetiana
dc.contributor.author	Vizir, Maryna
dc.contributor.author	Zhelezniakova, Natalia
dc.date.accessioned	2026-05-04T13:58:36Z
dc.date.issued	2026
dc.description.abstract	Metabolic dysfunction-associated steatotic liver disease (MASLD) is a progressive spectrum of liver diseases that begins with liver steatosis, followed by metabolic dysfunction-associated steatohepatitis (MASH) and may progress to liver fibrosis. The underlying mechanisms of MASLD are multifaceted and involve both genetic and non-genetic (epigenetic) factors.
dc.identifier.citation	Aleksandrova T. The role of histone modifications in the development of metabolic dysfunction-associated steatotic liver disease / T. Aleksandrova, M. Vizir, N. Zhelezniakova // Biomedical Perspectives VI : Abstract book of International Medical Conference of Students, Postgraduates and Young Scientists, Sumy, April 23─24, 2026. – Sumy : Sumy State University, 2026. – P. 102.
dc.identifier.uri	https://repo.knmu.edu.ua/handle/123456789/37962
dc.language.iso	en
dc.publisher	Sumy State University
dc.subject	metabolic dysfunction-associated steatotic liver disease
dc.subject	metabolic dysfunction-associated steatohepatitis
dc.subject	epigenetic
dc.subject	histone modifications
dc.subject	2026а
dc.title	The role of histone modifications in the development of metabolic dysfunction-associated steatotic liver disease
dc.type	Theses

Files

Now showing 1 - 2 of 2

Now showing 1 - 1 of 1